🔎 Trials Near Me

Akèy › Epilepsi myoklonik

Etid klinik pou Epilepsi myoklonik ap rekrite nan Etazini

7 etid pou Epilepsi myoklonik ap rekrite patisipan nan sit atravè Etazini.

Vil ki gen plis etid

Pa eta

Etid ki fèk mete ajou

Tèks ofisyèl etid la (Anglè)

A Fully Remote Feasibility Trial of Phenylbutyrate for SLC6A1-Related Disorders

Ap rekriteFaz 2
Laj 2 a 60 · Tout sèks · Mizajou Sep 29, 2026 · NCT07847918

A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome

Ap rekriteFaz 1/2
6 Months – 17 Years · Tout sèks · Mizajou Sep 22, 2026 · NCT05419492

A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome

Ap rekriteFaz 3
Laj 2 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT04462770

ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome

Ap rekriteFaz 1/2
Laj 2 a 12 · Tout sèks · Mizajou Sep 3, 2026 · NCT07531745

The FINTEPLA as an Anti-SUDEP Therapy in Dravet Syndrome Project

Ap rekriteFaz 4
Laj 16 ak plis · Tout sèks · Mizajou Jul 15, 2026 · NCT07112365

Assessment of Safety of the Use of Fenfluramine in Children With Dravet Syndrome Under 24 Months of Age

Ap rekriteFaz 4
12 Months – 24 Months · Tout sèks · Mizajou May 15, 2026 · NCT06598449

GABA Biomarkers in Dravet Syndrome

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Jiska laj 18 · Tout sèks · Mizajou Dec 14, 2022 · NCT05651204

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.